SOUTH CAROLINA REVENUE AND FISCAL AFFAIRS OFFICE
S
TATEMENT OF ESTIMATED FISCAL IMPACT
WWW.RFA.SC.GOV • (803)734-3793
This fiscal impact statement is produced in compliance with the South Carolina Code of Laws and House and Senate rules. The focus of
the analysis is on governmental expenditure and revenue impacts and may not provide a comprehensive summary of the legislation.
Page 1 of 2
S. 0477
Fiscal Impact Summary
This bill modifies the definition of “self-administered hormonal contraceptive” to explicitly
exclude an intrauterine device (IUD). This bill also allows pharmacists permitted to dispense
self-administered hormonal contraceptives to do so pursuant to written joint protocols by the
Board of Medical Examiners and the Board of Pharmacy. Further, this bill authorizes
pharmacists to dispense self-administered hormonal contraceptives under standing orders or
without a standing order when it is dispensed pursuant to written joint protocols by the Board of
Medical Examiners and the Board of Pharmacy.
The Department of Labor, Licensing, and Regulation (LLR) does not anticipate the bill will alter
the primary responsibilities of the agency, the Board of Medical Examiners, or the Board of
Pharmacy. LLR further anticipates that the expenditure impact to implement the provisions of
the bill will be minimal and can be managed within existing appropriations.
Explanation of Fiscal Impact
Introduced on March 20, 2025
State Expenditure
This bill modifies the definition of “self-administered hormonal contraceptive” to explicitly
exclude an IUD. This bill also allows pharmacists permitted to dispense self-administered
hormonal contraceptives to do so pursuant to written joint protocols by the Board of Medical
Examiners and the Board of Pharmacy. Further, this bill authorizes pharmacists to dispense self-
administered hormonal contraceptives under standing orders or without a standing order when it
is dispensed pursuant to written joint protocols by the Board of Medical Examiners and the
Board of Pharmacy.
LLR does not anticipate the bill will alter the primary responsibilities of the agency, the Board of
Medical Examiners, or the Board of Pharmacy. LLR further anticipates that the expenditure
impact to implement the provisions of the bill will be minimal and can be managed within
existing appropriations.
State Revenue
N/A
Bill Number: S. 0477 Introduced on March 20, 2025
Subject: Pharmac y Access
Requestor: Senate Medical Affairs
RFA Anal
yst(s): Welsh
Impact Date: April 2, 2025
__________________________________
Frank A. Rainwater, Executive Director
DISCLAIMER: THIS FISCAL IMPACT STATEMENT REPRESENTS THE OPINION AND INTERPRETATION OF THE
AGENCY OFFICIAL WHO APPROVED AND SIGNED THIS DOCUMENT. IT IS PROVIDED AS INFORMATION TO
THE GENERAL ASSEMBLY AND IS NOT TO BE CONSIDERED AS AN EXPRESSION OF LEGISLATIVE INTENT.
Page 2 of 2
S. 0477
Local Expenditure
N/A
Local Revenue
N/A